San Diego, CA, United States of America

Christopher Reading


 

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Christopher Reading: Innovator in Autoimmunity and Metabolic Disorders

Introduction

Christopher Reading is a notable inventor based in San Diego, CA, who has made significant contributions to the fields of autoimmunity and metabolic disorders. With a total of five patents to his name, he has focused on developing innovative formulations and methods that address critical health issues.

Latest Patents

Among his latest patents is the invention related to steroid tetrol solid state forms. This invention pertains to solid state forms of androst-5-ene-3β,7β,16α,17β-triol, along with formulations that utilize these solid state forms. These formulations are designed to modulate acute and chronic non-productive inflammation and can be used to prevent, treat, or slow the progression of autoimmune conditions such as arthritis, multiple sclerosis, ulcerative colitis, and Type 1 diabetes. Additionally, they can address metabolic disorders like Type 2 diabetes. Another significant patent involves a drug identification and treatment method, which focuses on identifying compounds that can treat autoimmune conditions and specific clinical disorders. The compounds identified include various forms of ethynylandrost-5-ene derivatives.

Career Highlights

Christopher Reading has worked with several prominent companies in the pharmaceutical industry, including Harbor Therapeutics, Inc. and Hollis-Eden Pharmaceuticals, Inc. His work has been instrumental in advancing therapeutic options for patients suffering from complex health conditions.

Collaborations

Throughout his career, Reading has collaborated with notable professionals in the field, including James M. Frincke and Clarence Nathaniel Ahlem. These collaborations have contributed to the development of innovative solutions in healthcare.

Conclusion

Christopher Reading's contributions to the fields of autoimmunity and metabolic disorders through his patents and collaborations highlight his role as a significant innovator. His work continues to pave the way for advancements in treatment options for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…